Header Logo

Connection

ROHTESH S MEHTA to Bortezomib

Back to Details
This is a "connection" page, showing publications ROHTESH S MEHTA has written about Bortezomib.
ROHTESH S MEHTA
Connection Strength
0.036
Bortezomib
  1. Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia. Clin Lymphoma Myeloma Leuk. 2019 09; 19(9):560-569.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.